Levodopa responsive parkinsonism in an adult with Huntington's disease

le Racette, B., Perlmutter, J.
Foilsithe 1998

Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease

le Hershey, T, Black, K, Carl, J, McGee-Minnich, L, Snyder, A, Perlmutter, J
Foilsithe 2003

Neurologist care in Parkinson disease: A utilization, outcomes, and survival study

le Willis, A.W., Schootman, M., Evanoff, B.A., Perlmutter, J.S., Racette, B.A.
Foilsithe 2011

Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease

le Hershey, T., Wu, J., Weaver, P.M., Perantie, D.C., Karimi, M., Tabbal, S.D., Perlmutter, J.S.
Foilsithe 2007

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

le Burack, M A., Hartlein, J, Flores, H P., Taylor-Reinwald, L, Perlmutter, J S., Cairns, N J.
Foilsithe 2010

Pathophysiology of parkinsonism due to hydrocephalus

le Racette, B, Esper, G, Antenor, J, Black, K, Burkey, A, Moerlein, S, Videen, T, Kotagal, V, Ojemann, J, Perlmutter, J
Foilsithe 2004

Reduced uptake of [(18)F]FDOPA PET in asymptomatic welders with occupational manganese exposure

le Criswell, S.R., Perlmutter, J.S., Videen, T.O., Moerlein, S.M., Flores, H.P., Birke, A.M., Racette, B.A.
Foilsithe 2011

Amyloid imaging of Lewy body-associated disorders

le Foster, E.R., Campbell, M.C., Burack, M.A., Hartlein, J., Flores, H.P., Cairns, N.J., Hershey, T., Perlmutter, J.S.
Foilsithe 2010

Neural correlates of STN DBS-induced cognitive variability in Parkinson disease

le Campbell, M.C., Karimi, M., Weaver, P.M., Wu, J., Perantie, D.C., Golchin, N.A., Tabbal, S.D., Perlmutter, J. S., Hershey, T.
Foilsithe 2008

A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE End of Life Planning

le Carlozzi, N.E., Hahn, E.A., Frank, S., Perlmutter, J.S., Downing, N.D., McCormack, M.K., Barton, S., Nance, M.A., Schilling, S.G.
Foilsithe in J Neurol (2017)

HDQLIFE: The development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties and Swallowing Difficulties

le Carlozzi, N. E., Schilling, S.G., Lai, J.-S., Perlmutter, J.S., Nance, M.A., Waljee, J.F., Miner, J.A., Barton, S.K., Goodnight, S.M., Dayalu, P.
Foilsithe in Qual Life Res (2016)

Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease

le Karimi, M., Golchin, N., Tabbal, S. D., Hershey, T., Videen, T. O., Wu, J., Usche, J. W. M., Revilla, F. J., Hartlein, J. M., Wernle, A. R., Mink, J. W., Perlmutter, J. S.
Foilsithe 2008

Cerebral blood flow responses to dorsal and ventral STN DBS correlate with gait and balance responses in Parkinson disease

le Hill, K.K., Campbell, M.C., McNeely, M.E., Karimi, M., Ushe, M., Tabbal, S.D., Hershey, T., Flores, H.P., Hartlein, J.M., Lugar, H.M., Revilla, F.J., Videen, T.O., Earhart, G.M., Perlmutter, J.S.
Foilsithe 2012

New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient reported outcomes measurement syste...

le Carlozzi, N.E., Downing, N.R., McCormack, M.K., Schilling, S.G., Perlmutter, J.S., Hahn, E. A., Lai, J.-S., Frank, S., Quaid, K.A., Paulsen, J. S., Cella, D., Goodnight, S.M., Miner, J.A., Nance, M.A.
Foilsithe in Qual Life Res (2016)

Clinimetric Testing of the Comprehensive Cervical Dystonia Rating Scale

le Comella, C. L., Perlmutter, J.S., Jinnah, H. A., Waliczek, T. A., Rosen, A. R., Galpern, W. R., Adler, C. H., Barbano, R. L., Factor, S. A., Goetz, C.G., Jankovic, J., Reich, S. G., Rodriguez, R. L., Severt, W. L., Zurowski, M., Fox, S. H., Stebbins, G.T.
Foilsithe in Mov Disord (2016)

Novel THAP1 sequence variants in primary dystonia

le Xiao, J, Zhao, Y, Bastian, R W., Perlmutter, J S., Racette, B A., Tabbal, S D., Karimi, M, Paniello, R C., Wszolek, Z K., Uitti, R J., Van Gerpen, J A., Simon, D K., Tarsy, D, Hedera, P, Truong, D D., Frei, K P., Dev Batish, S, Blitzer, A, Pfeiffer, R F., Gong, S, LeDoux, M S.
Foilsithe 2010

HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD)

le Carlozzi, N. E., Schilling, S. G., Lai, J.-S., Paulsen, J. S., Hahn, E. A., Perlmutter, J. S., Ross, C. A., Downing, N. R., Kratz, A. L., McCormack, M. K., Nance, M. A., Quaid, K. A., Stout, J. C., Gershon, R. C., Ready, R. E., Miner, J. A., Barton, S. K., Perlman, S. L., Rao, S. M., Frank, S., Shoulson, I., Marin, H., Geschwind, M. D., Dayalu, P., Goodnight, S. M., Cella, D.
Foilsithe in Qual Life Res (2016)

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: The GenePD Study

le Tobin, J.E., Latourelle, J.C., Lew, M.F., Klein, C., Suchowersky, O., Shill, H.A., Golbe, L.I., Mark, M.H., Growdon, J.H., Wooten, G.F., Racette, B.A., Perlmutter, J.S., Watts, R., Guttman, M., Baker, K.B., Goldwurm, S., Pezzoli, G., Singer, C., Saint-Hilaire, M.H., Hendricks, A.E., Williamson, S., Nagle, M.W., Wilk, J.B., Massood, T., Laramie, J.M., DeStefano, A.L., Litvan, I., Nicholson, G., Corbett, A., Isaacson, S., Burn, D.J., Chinnery, P.F., Pramstaller, P.P., Sherman, S., Al-hinti, J., Drasby, E., Nance, M., Moller, A.T., Ostergaard, K., Roxburgh, R., Snow, B., Slevin, J.T., Cambi, F., Gusella, J.F., Myers, R.H.
Foilsithe 2008